A Phase 1, Single-Center, Open-Label, 2-Arm Parallel Group, Single-Dose Study to Evaluate the Pharmacokinetics of Dexlansoprazole 30 mg and 60 mg Delayed-Release Capsules in Healthy Chinese Subjects
收藏DataCite Commons2025-10-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00007409/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to assess the pharmacokinetics after a single dose of
dexlansoprazole 30 and 60 mg delayed-release capsules in healthy Chinese participants.
本研究旨在评估健康中国受试者单次服用30mg与60mg右兰索拉唑（dexlansoprazole）迟释胶囊后的药代动力学（pharmacokinetics）。
提供机构：
Vivli
创建时间：
2021-09-22
